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Abstract
Background: Despite the prevalence of mobile health (mHealth) technologies and observations of their impacts on patients’
health, there is still no consensus on how best to evaluate these tools for patient self-management of chronic conditions. Researchers
currently do not have guidelines on which qualitative or quantitative factors to measure or how to gather these reliable data.
Objective: This study aimed to document the methods and both qualitative and quantitative measures used to assess mHealth
apps and systems intended for use by patients for the self-management of chronic noncommunicable diseases.
Methods: A scoping review was performed, and PubMed, MEDLINE, Google Scholar, and ProQuest Research Library were
searched for literature published in English between January 1, 2015, and January 18, 2019. Search terms included combinations
of the description of the intention of the intervention (eg, self-efficacy and self-management) and description of the intervention
platform (eg, mobile app and sensor). Article selection was based on whether the intervention described a patient with a chronic
noncommunicable disease as the primary user of a tool or system that would always be available for self-management. The
extracted data included study design, health conditions, participants, intervention type (app or system), methods used, and measured
qualitative and quantitative data.
Results: A total of 31 studies met the eligibility criteria. Studies were classified as either those that evaluated mHealth apps (ie,
single devices; n=15) or mHealth systems (ie, more than one tool; n=17), and one study evaluated both apps and systems. App
interventions mainly targeted mental health conditions (including Post-Traumatic Stress Disorder), followed by diabetes and
cardiovascular and heart diseases; among the 17 studies that described mHealth systems, most involved patients diagnosed with
cardiovascular and heart disease, followed by diabetes, respiratory disease, mental health conditions, cancer, and multiple illnesses.
The most common evaluation method was collection of usage logs (n=21), followed by standardized questionnaires (n=18) and
ad-hoc questionnaires (n=13). The most common measure was app interaction (n=19), followed by usability/feasibility (n=17)
and patient-reported health data via the app (n=15).
Conclusions: This review demonstrates that health intervention studies are taking advantage of the additional resources that
mHealth technologies provide. As mHealth technologies become more prevalent, the call for evidence includes the impacts on
patients’ self-efficacy and engagement, in addition to traditional measures. However, considering the unstructured data forms,
diverse use, and various platforms of mHealth, it can be challenging to select the right methods and measures to evaluate mHealth
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technologies. The inclusion of app usage logs, patient-involved methods, and other approaches to determine the impact of mHealth
is an important step forward in health intervention research. We hope that this overview will become a catalogue of the possible
ways in which mHealth has been and can be integrated into research practice.
(JMIR Mhealth Uhealth 2020;8(4):e16814) doi: 10.2196/16814
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mobile health; apps; self-management; chronic disease; noncommunicable diseases; interventions; patient-centered approach;
patient-operated intervention
Introduction
Need for Mobile Health Evaluation
Health research is yet to agree upon a framework for evaluating
mobile health (mHealth) interventions. This is especially true
for tools, such as apps and wearables, that are intended primarily
to aid patients in health self-management. Traditionally, the
evaluation of mobile medical devices has been based on clinical
evidence, and it can take years to bring these devices to the
market. The continuous glucose monitor first came onto the
market in 1999, but it was not until 2006 that the next version
was available [1]. Similarly, the pulse oximeter struggled for
decades to become a standard mobile tool for measuring blood
oxygenation [2]. Because there are increasingly easy-to-use
patient-operated mHealth technologies available on the market,
patients are no longer willing to wait for a lengthy evaluation
process. Instead, patients often use apps without assurance of
quality or guidance from their health care providers [3].
Always-Available Self-Management Technologies
Individuals are more empowered to take greater responsibility
for their health, and currently, they enthusiastically seek out
mHealth apps and other devices for self-management. For
chronic conditions in particular, health challenges occur
continuously, not just when it is convenient or at a doctor’s
office. Technologies for self-management must allow individuals
to register and review the measurements that they input into the
app or system at any time. Connectivity to devices, such as
medical or commercial sensors and wearables, adds to the utility
of an app. A report by Research2Guidance [4], an organization
that provides market research on digital health, emphasized the
central role of patient-operated mHealth apps in the
“connectivity landscape” of electronic health technologies [5].
However, their diverse functionalities and intended uses pose
great challenges to researchers.
Challenges of mHealth Evaluation: Single Apps Versus
Multiplatform Interventions
The amount of assessment and testing that is necessary for health
technology is directly related to its potential risks and benefits
[6,7]. For example, medications based on patient-gathered health
data are associated with higher health risks than those in patients
with type 2 diabetes who seek motivation from an activity
tracker for weight management. Although multiplatform (ie,
system) interventions serve to increase the benefits (eg,
automatic and less burdensome operations), they increase the
risks related to data safety, integrity, and reliability [8,9].
Researchers must adapt their approaches, methods, and measures
for patient self-management interventions involving single
mHealth apps and those involving multiplatform systems.
Evaluation Framework: Coverage
There are two main categories of mobile medical or mHealth
devices associated with the amount of oversight health
authorities will show; those that are “actively regulated” and
those that fall under “enforcement discretion.” These categories
are described in the 2015 Guidance for Industry and Food and
Drug Administration Staff [10] and are echoed in the updated
2019 Guidance [11] and included in the terms of The European
Economic Area Certification (CE) Mark [12]. Devices that are
actively regulated are required to undergo an evaluation and
meet security and effectiveness standards for use in health care.
On the other hand, many patient-operated technologies fall
under “enforcement discretion,” and they pose less risk to patient
safety and health. For individuals aiming to assess the usefulness
or safety of these technologies, there are no evaluation
frameworks or guidelines to follow. The year 2015 marked a
relevant change in the mHealth arena, which we are still
exploring today (connectivity between different device types,
development on different platforms, and marked focus on
mHealth integration into clinical practice) [13].
Although there have been many strategies [14-17] for the
evaluation of this subset of mHealth (eg, National Institute for
Health and Care Excellence [18]), there is no agreement about
which qualitative or quantitative measures should be addressed
or how they should be evaluated [19]. Evaluation frameworks,
such as the World Health Organization (WHO) mHealth
evidence reporting and assessment (mERA) checklist [20],
suggest that traditional health research measures and methods
are not sufficient. For assessing the comprehensive impacts of
such patient-operated mHealth approaches, research needs to
look into additional factors. This can be achieved by producing
evidence that is relevant for both patients and clinicians.
Additional Factors for mHealth Evaluation
Although clinical evidence is essential for the evaluation of any
health aid, the two major concepts of time and human behavior
must also be addressed in mHealth evaluation. As “always
available” technologies are being used continuously and
uniquely by patients, it is uncertain how much time is needed
to produce an effect and what changes in self-management
behavior will occur. Traditionally, medical devices rely on
established biological knowledge, have fewer alternatives in
the market, and do not offer frequent updates. However,
patient-operated mHealth approaches require the consideration
of patients’ motivation, health beliefs, and resources for
self-management. They must also compete with hundreds of
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other mHealth apps and devices that are continuously developed
and updated. In recent years, clinical research has attempted to
keep pace with mHealth by employing methods that aim to
expedite the research process and produce more tailored
knowledge for the field of mHealth [21].
Stakeholders associated with chronic health and care
(researchers, individuals, health care providers, and health care
authorities) have been calling for evidence related to the personal
use of mHealth technologies for many years [22-24]. Regardless
of the beneficial or harmful outcomes, we need to know their
potential. Without such evidence, people in the health care field
will not be able to effectively support and guide individuals in
the use of these technologies for health self-management. This
evidence must be obtained with appropriate questions and
methods.
Recent scoping reviews of mHealth technologies for chronic
conditions focused on evidence as it relates to a specific age
group [25], the development process [26], or clinical outcomes
[27] and not on how the research was performed or which
resources were used in the evaluation. The purpose of this
scoping review was to identify which methods were used and
which qualitative and quantitative data were measured to assess
patient-operated mHealth devices for the self-management of
chronic noncommunicable diseases (NCDs). As evidence for
health authorities and health care providers, quantitative clinical
outcomes have historically been considered the primary target
for evaluation [28]; however, given the growing trend of
mHealth, we included qualitative measures of participants’ use
of and experiences with the technology.
Research Questions
The research questions were as follows: (1) What methods are
used to evaluate patient-operated mHealth apps and systems
for self-management of chronic NCDs? (2) Which qualitative
and quantitative measures are used to evaluate the impact of
patient-operated mHealth apps and systems for self-management
of chronic NCDs?
Methods
Scoping Review Objective
We performed a scoping review to document how researchers
have evaluated mHealth interventions for self-management of
chronic NCDs. Munn et al [29] stated that scoping reviews are
favored over other review types in cases in which researchers
are using an evolving set of methods owing to the novelty of
the field or where the purpose of the review is to inform future
questions about the field. We intended to provide an overview
of what methods researchers use and which qualitative and
quantitative measures were adopted to evaluate mHealth
self-management interventions. This review reports information
according to the Preferred Reporting Items for Systematic
review and Meta-Analyses extension for Scoping Reviews
(PRISMA-ScR) checklist (Multimedia Appendix 1).
Search Strategy and Databases
The scope of the search and definitions of mHealth were
discussed among the coauthors (MB, EG, EÅ, and MJ). The
databases searched for scientific literature were PubMed,
MEDLINE, Google Scholar, and ProQuest Research Library.
PubMed and MEDLINE were both included because PubMed
includes citations that are not yet indexed in MEDLINE [30].
We searched for articles published in English between January
1, 2015, and January 18, 2019, which were related to the
evaluation of patient-operated mHealth interventions for
self-management of chronic NCDs. The search string included
key terms describing the intervention’s intended use (ie,
self-efficacy, self-assessment, self-management, or
self-monitoring) and the intervention’s platform (ie, mobile
phones, wearables, sensors, or apps). The full search string was
used for titles and abstracts, and the format was adapted to the
database being searched (Multimedia Appendix 2).
Medical Subject Headings (MeSH) terms were not considered
because our search included articles published recently, which
may contain terminology that has not yet been indexed within
the MeSH database. The identified abstracts and titles were
collected in EndNote [31] and then uploaded into Rayyan [32],
an online “library systematic review service” that allows
researchers to collaborate on the organization, inclusion, and
exclusion of articles for literature review.
Eligibility Criteria
We aimed to include research efforts that may have addressed
new guidelines for mobile medical devices. Within our broad
search criteria for low-risk mHealth apps and systems, articles
were eligible for inclusion if they described low-risk
technologies consistent with the FDA and CE Markings’
description of mobile medical devices under “enforcement
discretion” [10-12]. Multimedia Appendix 3 describes the
specificities of this subcategory.
A preliminary search was performed, and a random selection
of 10 articles was reviewed for inclusion or exclusion by two
authors (MB and EG). Refinements were made to the review
criteria.
For this review, we included studies that evaluated interventions
involving (1) mHealth technologies for chronic NCDs, including
the primary NCDs listed by the WHO [33] (ie, diabetes, cancer,
cardiovascular diseases, chronic respiratory diseases, and
chronic mental health conditions); (2) mHealth technologies
for self-management (tasks which a person must perform in
order to manage the symptoms, treatment, physical and
psychosocial consequences, and lifestyle changes inherent in
living with a chronic condition, and efficacious self-management
was considered to encompass the ability to monitor one’s
condition and to affect the cognitive, behavioral, and emotional
responses necessary to maintain a satisfactory quality of life)
[34]; and (3) mHealth technologies that allow the patient to
choose which measures to register and review.
The details of the inclusion and exclusion criteria are described
in Multimedia Appendix 4, and they were used during the main
review search.
Data Extraction and Synthesis
After removing duplicate articles, reviews, and protocol articles
without evaluation results, two authors (MB and PJ)
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independently screened the titles and abstracts for eligibility
according to the inclusion and exclusion criteria. In case of
disagreement regarding eligibility, another author (EG) was
called to join the discussion until an agreement was reached.
Author MB reviewed the full-text articles and performed data
extraction.
The identified studies were classified as either those that
evaluated mHealth apps or mHealth systems. Interventions that
included a single app were grouped as mHealth apps, whereas
those that included services or devices connected to a central
app were grouped as mHealth systems. In this way, we could
more clearly assess the different approaches taken by researchers
when addressing the various impacts of these two mHealth
intervention types.
Abilities of Studies to Produce Results
For both groups, one author (MB) assessed whether a study was
able to produce the evidence that it aimed to obtain, using the
selected methods. This was performed by comparing the
objectives as stated by the authors of the identified articles to
the methods and reported results. The studies were judged
according to their ability to produce the information, and the
findings were reported as yes, yes and more than expected, no,
and cannot tell. The results of these comparisons are detailed
in Multimedia Appendix 5.
Results
Overview
Among 3912 records identified by the search criteria, we
reviewed 55 full-text articles and included 31 studies for data
extraction and synthesis. Figure 1 illustrates the process of
identifying the relevant articles for inclusion in data extraction.
Figure 1. Flow diagram illustrating the selection of studies for inclusion in data synthesis. NCD: noncommunicable disease.
Summary of Studies: Apps Versus Systems
Among the 31 studies chosen for data extraction, 15 were
categorized as those that evaluated mHealth apps and 17 were
categorized as those that evaluated mHealth systems. One study
evaluated both apps and systems [35] and was therefore included
in both categories. General information about the selected
studies that evaluated mHealth apps are summarized in Table
1 [35-49] and those that evaluated mHealth systems are
summarized in Table 2 [35,50-65].
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Table 1. Information about the studies that evaluated mHealth apps.
Intended sec-
ondary users
Health care
provider and
caregiver
participants
Patient partici-
pants
Health conditionDurationStudy designCountryYearApp nameReference
N/AN/AaPatients
(n=84)
Type 2 diabetes8 weeksProspective
study
Singapore2015Diet and Ac-
tivity Track-
er (iDAT)
[36]
N/AN/APatients
(n=90)
DiabetesSingle evalua-
tion
Cross-section-
al study
Korea2015Diabetes
Notepad
[37]
N/AN/APatients
(n=54)
Bipolar disorder72 weeksProspective
study
Germany2015Personal
Life-chart
app
[38]
N/AN/APatients
(n=24) and re-
searchers
Heart diseasesSingle evalua-
tion
Cross-section-
al study
USA2015HeartKeeper[39]
N/AN/APatients
(n=32)
Heart diseases36 weeksRetrospective
study
Spain2016HeartKeeper[40]
N/AN/ACurrent users
(n=156)
Post-traumatic
stress disorder
Duration of
availability of
the app on app
stores
Retrospective
study
USA2015PTSD Coach[41]
Health care
providers
Health care
providers
(n=3)
Patients
(n=10)
Post-traumatic
stress disorder
16 weeksRCTbUSA2015PTSD Coach[42]
N/AN/APatients
(n=49)
Post-traumatic
stress disorder
4 weeksRCTUSA2016PTSD Coach[43]
N/AN/APatients
(n=120)
Post-traumatic
stress disorder
24 weeksRCTUSA2017PTSD Coach[44]
N/ANurses (n=3)
and experts
(n=5)
Patients
(n=38)
HypertensionSingle event
evaluation
—cKorea2016Hyperten-
sion manage-
ment app
(HMA)
[45]
Family,
friends, and
health care
providers
(not all apps)
N/AApps (n=34)Heart failureSingle evalua-
tion
Cross-section-
al study
USA2016Multiple
commercial
apps for
heart failure
[35]d
N/ACaregivers
(n=9)
Patients
(n=20)
MultipleSingle evalua-
tion
Cross-section-
al study
USA2016Multiple
commercial
apps (n=11)
[46]
N/AN/APatients
(n=10)
Serious mental
health condi-
tionse
Single evalua-
tion
Cross-section-
al study
USA2017I-IMR inter-
vention
[47]
N/AHealth care
providers
Patients (n=7)Type 2 diabetes16 weeksProspective
study
Israel2017Serenita[48]
N/AN/APatients
(n=34)
Depression and
anxiety
6 weeksRetrospective
study
USA2018Sinasprite
database
[49]
aN/A: not applicable.
bRCT: randomized controlled trial.
cNot available.
dStudy evaluated both apps and systems and therefore will appear in both categories.
eCombination of cardiovascular disease, obesity, diabetes, high blood pressure, high cholesterol, osteoporosis, gastroesophageal reflux disease,
osteoarthritis, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, and bipolar disorder, major depressive disorder,
schizophrenia, or schizoaffective disorder [47].
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Table 2. Information about the studies that evaluated mHealth systems.
Other de-
vices in-
cluded
Medical
device in-
cluded
(Y/N)
Others in-
volved in
the inter-
vention
Intended sec-
ondary users
ParticipantsHealth condi-
tion
DurationStudy de-
sign
CountryYearInterven-
tion name
Refer-
ence
Blood
pressure
YHealth
care
Health care
providers
Patients
(n=26)
Heart failure45 weeksCross-sec-
tional
study
UK2015SUP-
PORT-HF
Study
[50]
monitor,
weight
providers
and infor-
scales,mal care
givers and pulse
oximeter
Glucose
meter
YHealth
care
providers
Health care
providers
Patients
(n=87) and
health care
providers
(n=5)
DiabetesSingle
evalua-
tion
Cross-sec-
tional
study
USA2015—a[51]
Wearable
activity
NN/AcHealth care
providers
Patients
(n=10)
Serious men-
tal health con-
ditionb
80-100
days
(mean
12.5
weeks)
Prospective
study
USA2015Multiple
commer-
cial tech-
nologies
for activity
tracking
[52]
monitor-
ing de-
vices
and peers
(optional)
Smart-
watch
YN/AN/APatients
(n=6)
Type 1 dia-
betes
2 weeksProspective
study
Norway2015Diabetes
Diary app
[53]
app and
glucose
meter
Glucose
meter
YN/AN/APatients
(n=30)
Type 1 dia-
betes
23 weeksRCTdNorway2015Diabetes
Diary app
[54]
Glucose
meter
YN/AHealth care
providers
Patients
(n=151)
Type 2 dia-
betes
48 weeksRCTNorway2016Diabetes
Diary app
[55]
Peak flow
meter
YResearch
team
N/APatients
(n=44)
Asthma8 weeksProspective
study
Korea2016SnuCare[56]
Withings
blood
YHealth
care
providers
Health care
providers
Patients
(n=52)
Hypertension24 weeksRCTUSA2016HealthyCir-
cles Plat-
form
[57]
pressure
monitor
Fitbit ZipNN/AN/APatients
(n=11)
Serious men-
tal health con-
ditionb
24 weeksProspective
study
USA2016Multiple
commer-
cial tech-
nologies
[58]
for activity
tracking
YNN/AFamily,
friends, and
Apps (n=34)StrokeSingle
evalua-
tion
Cross-sec-
tional
study
USA2016Multiple
commer-
cial apps
for heart
failure
[35]e
health care
providers
(not all apps)
NNHealth
care
providers
Health care
providers
Patients
(n=8) and
health care
providers
(n=6)
Multiple4 weeksProspective
study
Canada2016Electronic
Patient Re-
ported Out-
come tool
(ePRO)
[59]
Activ-
PAL™
NN/APeers (auto-
matic)
Patients
(n=23)
Stroke6 weeksProspective
study
UK2016STARFISH[60]
activity
monitor
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Other de-
vices in-
cluded
Medical
device in-
cluded
(Y/N)
Others in-
volved in
the inter-
vention
Intended sec-
ondary users
ParticipantsHealth condi-
tion
DurationStudy de-
sign
CountryYearInterven-
tion name
Refer-
ence
Zephyr
Biohar-
ness or
Biopatch
YHealth
care
providers
Health care
providers
Patients
(n=25) and
health care
providers
(n=12)
Heart failureSingle
evalua-
tion
Cross-sec-
tional
study
USA2016HeartMapp[61]
NNInformal
care
givers
Health care
providers
(automatic)
Patients
(n=110) and
research
nurses (n=2)
Chronic ob-
structive pul-
monary dis-
ease
48 weeksRCTUK2017EDGE digi-
tal health
system
[62]
iBGStar
blood glu-
cose me-
ter
YN/AN/APatients
(n=51)
Diabetes12 weeksProspective
study
Ger-
many
2017IBGStar
Diabetes
Manager
Applica-
tion
[63]
Weight
scale,
blood
pressure
monitor,
and glu-
cose me-
ter
YNursesNurses (auto-
matic)
Patients
(n=8) and
nurses
Heart failure24 weeksProspective
study
USA2017MyHeart[64]
NNN/APeers and
health care
providers
Patients
(n=23)
Cancer4 weeksCross-sec-
tional
study
UK2018—[65]
aNot available.
bSchizophrenia spectrum disorder, bipolar disorder, or major depressive disorder [52,58].
cN/A: not applicable.
dRCT: randomized controlled trial.
eStudy evaluated both apps and systems and therefore will appear in both categories.
App interventions mainly targeted mental health conditions
(n=7), followed by diabetes (n=3) and cardiovascular and heart
diseases (n=4), with one study evaluating multiple apps that
were used to self-manage multiple health conditions (Table 1).
Patients were included in all studies, and the studies had between
3 and 156 participants (median 36, IQR 15-87, maximum 156).
The exception was one study in which only researchers
evaluated patient-operated apps according to Google
recommendations and quality standards [35,39]. Although
studies tested single apps intended to be used primarily by
patients, two studies also explored the impact of patients sharing
their collected data with health care providers [35,42].
Six studies utilized single evaluations, either through a
cross-sectional design [35,37,39,45-47] or an analytic service
to analyze data available through the app store [41]. The
remaining studies evaluated the impacts of app use over time,
lasting between 4 and 72 weeks, with a mean period of 22.75
weeks (median 16 weeks, IQR 6-36, maximum 72). Of these,
four utilized prospective study designs, three were randomized
controlled trials (RCTs), and two used a retrospective design.
Among the 17 studies that described mHealth systems, most
involved patients diagnosed with cardiovascular and heart
disease (n=6), followed by diabetes (n=5), respiratory disease
(n=2), mental health conditions (n=2), cancer (n=1), and
multiple illnesses (n=1; Table 2).
As with mHealth app studies, all system studies, except one
[35], involved patients. The 16 studies had between 6 and 151
patients (median 30, IQR 14.5-51.5, maximum 151), with eight
studies involving health care providers. In these cases, health
care providers either provided input on the suitability of an app
for patient use or reviewed patient-gathered data during
consultations.
In 12 studies, patients were required to share data (n=6)
[50,51,57,60,62,64] or encouraged to share data (n=6)
[35,53,55,59,61,65] with their health care providers or peers as
part of the study. Data were also collected and transmitted to
the main app by medical devices [50,51,53-57,61,63,64] and
commercial wearables [35,52,53,58,60], demonstrating the
prevalence of connectivity in modern mHealth systems.
Few studies (n=3) used single evaluations. RCTs (n=4) lasted
longer (35.75 weeks on average) than cross-sectional studies
(mean 24.5 weeks, n=2) and prospective studies (mean 12.93
weeks, n=7). Overall system evaluations lasted a mean of 20.32
weeks, which is very close to that for app interventions, but
with a higher median number of 23 weeks.
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Methods and Measures
Most studies included a combination of qualitative and
quantitative methods of evaluation. Evaluation of usage logs
was the most commonly adopted method (21 studies), followed
by standardized questionnaires (17 studies; Table 3). Only two
studies adopted quality guidelines to evaluate mHealth
interventions; the Mobile Application Rating Scale was used
to evaluate multiple apps [35], and compliance with Google
standards for Android systems, in addition to other approaches,
was used to evaluate the HeartKeeper app [39].
Table 3. Categories of methods used to evaluate mHealth interventions.
Studies that evaluated mHealth systemsStudies that evaluated mHealth appsMethods (adopted approaches)
[50,52,54,56-59,62-64][36,38,40-42,44,48,49]Evaluation of usage logs
[35,55-57,60,64][35-39,41-45,48,49]Standardized questionnaires
[51,53,55-58,61-63][36,37,40,42-44,47]Ad-hoc questionnaires
[50,52,58,59,65][40,45,46]Interviews
[54-56,63,64][36,48]Clinical outcomes
[35,53,62][35,41,43,45]Open feedback (ie, oral or written)
[54,56,57,60,62,64]N/AaCollection of additional device data (eg, medical device data)
[61,65][46,47]Field study and observation
[59,64]N/AFocus groups
N/A[45,47]Observational tests (in a lab setting)
[35][35,39]Quality guidelines
[63][42]Medical record entries
N/A[42,48]Attendance (intervention assigned activities/meetings)
N/A[41]Download count
aN/A: not applicable.
Among the 14 ad-hoc questionnaires used, four were developed
according to concepts or questions from standardized
questionnaires [47,58,61,62]. Similarly, two studies included
interviews, where the interview guides were based on
standardized questionnaires [40,45]. Some standardized
questionnaires were used in more than one study. Multimedia
Appendix 6 lists these questionnaires and illustrates the
combination of questionnaires used in each study. Compared
with traditional medical device testing, relatively few studies
included information gathered from medical record entries
(n=2), clinical outcomes (n=9), or observational tests (n=2).
Of note, some studies inferred more information from usage
logs than the count and type of app interactions and
patient-gathered data. For example, Triantafyllidis et al [50]
interpreted information from the evaluation of usage logs on
the usability of the device and participants’ engagement in the
study. The complete set of the types of data that were measured
and collected by the mHealth app and system intervention
studies are listed in Table 4.
JMIR Mhealth Uhealth 2020 | vol. 8 | iss. 4 | e16814 | p. 8https://mhealth.jmir.org/2020/4/e16814
(page number not for citation purposes)
Bradway et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Table 4. Categories of qualitative and quantitative data that were measured to evaluate mHealth interventions.
Studies that evaluated mHealth systemsStudies that evaluated mHealth appsTypes of data measured
[50,52,53,56-59,62-65][36,37,40-42,44,45,49]Interactions (via app)
[35,52,53,56,58,59,61,62,65][35,37,39-42,45,47]Usability/feasibility
[50,54,55,57,59,62-64][36-38,41,45,49]Patient-gathered self-management data (via app)
[35,50,51,53,56,58,59,64,65][35-37,40,42,43,45,48]Efficacy/effectiveness
[54-57,60,62-64][36,40,42,48]Physical well-being
[35,51-53,58,64,65][35,40,41,45-47]Perceptions, opinions, and suggestions
[50,52,58,59,64,65][39,41,46,47]Intervention experiences
[55,60,62][38,41,42,44,49]Psychological well-being
[56,63][40-44]Patient-reported health
[55,57,61][36,44,47,49]Self-efficacy
[50,52,56,63][36,41]Engagement/motivation in self-management
[56,59,62-64][42]Health care utilization and impact
[50,61,65][45-47]Task performance
[35][35,41,42,48,49]Study engagement
[53,58,59][43,44]Patient-reported app use
[52,57,60][36,37]Patient-reported self-management
[55,56,60,64][48]Quality of life
[35][35,39,41,47]App features and quality
[62,65]N/AaEfficiency
[51][39]Security
N/A[48]Lifestyle
aN/A: not applicable.
Although a single method can often provide information
regarding more than one measure, over one-third of the studies
in this review used more than one method to collect information
on one type of measure [40,42,45,48,50,55-60]. For example,
two studies used both the collection of additional device data
and clinical outcomes to report physical well-being [54,64].
Multimedia Appendix 7 includes a description of which
measures were produced by each method. Several of the studies
collected information on twice as many types of data measured
as methods used to collect them (n=9) [35,41,44,49,58-60,65],
with two studies collecting three [51,52] and one collecting four
[39] times the number of types of data measured as methods
used to collect them. Only one study used four methods to
evaluate the most unique data types that were measured (n=10)
by utilizing information resources that mHealth technologies
make available (eg, automatically collected data from current
users in the Android app store) [41].
Conversely, measures can be reported using more than one
method. For example, usability/feasibility was the most common
measure (22 times in 17 studies), followed by
efficacy/effectiveness (20 times in 16 studies), interactions (via
app; 19 times in 19 studies), physical well-being (18 times in
13 studies), and patient-gathered self-management data (via
app; 15 times in 14 studies; Multimedia Appendix 7).
The study by Possemato et al [42] described the only app
intervention that measured health care utilization and impact
from these methods. Kim et al [56], Alnosayan et al [64], and
Sieber et al [63] described system interventions that measured
health care utilization or impact (ie, hospitalizations reported
by participating health care providers and hospitalizations
recorded retroactively). The remaining studies (n=5) collected
information regarding physical well-being from clinical
outcomes measured by researchers or health care providers
during follow-up [36,48,54,55,61].
More comprehensive mapping of methods and measures
revealed that the methods that were used to produce the most
diverse set of data were, as expected, interviews (n=9),
standardized questionnaires (n=16), and study-specific
questionnaires (n=13; Multimedia Appendix 7). However,
evaluation of usage logs produced nearly as many different
types of measures (n=8).
Objectives and Methods Versus Results
A comparison of the study objectives with the results
demonstrated that 30 of the 31 studies reported the results that
they intended. One study reported all but one of the intended
results described in the original objectives (ie, whether the
reviewed apps and systems had been previously validated) [35].
Ten studies reported more than they anticipated, some of which
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included the assessment of app [42,48] and system [50] usage
patterns, as well as comparisons with other outcomes [41,44].
Other unforeseen outcomes included the accuracy of the app’s
knowledge base, as evaluated by nurses [45]; usability according
to patients’ performance of predetermined tasks with the app
[47]; usability of connected devices in an mHealth system [53];
health care utilization [56]; and patient-reported symptoms [63].
Two studies stated that the objective was to develop mHealth
systems; however, their outcomes also included evaluation
results [50,51]. None of the studies phrased their goals as
research questions and some reported what they intended, but
the objective was not explicitly stated or detailed [40,63]. For
example, Velardo et al [62] stated their intention to evaluate
their intervention at scale. However, it was not clear how they
intended to “evaluate” their intervention.
Discussion
Principal Findings
We identified 31 studies that described evaluations of mHealth
apps or systems, with one describing evaluation of both
intervention types [35]. Our findings show that studies relied
mostly upon more continuous measures. Except for the
collection of additional device data used by system interventions
but not app interventions, there were no significant differences
between apps and systems with regard to their ability to produce
the intended outcomes, health conditions, or types of methods
or measures used within the studies. Overall, medical record
entries [42], attendance of meetings or activities assigned by
the intervention [63], and download count [41] were the least
used methods for gathering information about an intervention’s
impact on patients and providers. On the other hand, evaluation
of usage logs [36,38,40-42,44,48-50,52,54,56-59,62-64] and
standardized questionnaires [35-39,41-45,48,49,55-57,60,64]
were the most commonly used methods. These two approaches
(ie, one traditional and one mHealth) were also commonly used
together in the same studies, demonstrating that mHealth is
supplementing, not replacing, traditional research approaches.
mHealth Trends Versus Methods and Measures Used
Although clinical integration of mHealth technologies is on the
rise, only two studies described app interventions that were
meant to be used by secondary users (ie, health care providers
and family and friends) [35,42], with three involving health
care providers in the evaluation process [42,45,48]. Despite the
focus on data safety and security, as well as patient privacy, as
described by the new General Data Protection Regulation [66]
and established FDA [10,11] and CE marking [12] expectations
for health-related technologies, only two studies included
measures regarding security [39,51].
Need to Reassess Evaluation Standards
Health evaluation studies are meant to produce evidence and
understanding of how various interventions could affect patients
and providers in real-world health care settings. Traditionally,
studies have been classified within a hierarchy based on their
designs, methods, and measures used to evaluate health
interventions [67]. Health professionals consider high-level
studies to be those that use rigorous and strict study designs,
such as RCTs [68]. These studies provide an objective and
quantitative understanding of how an intervention would
influence patient clinical health measures, cost, or health care
resource use [69]. On the other hand, low-level studies are often
those that rely upon subjective and flexible study designs (eg,
qualitative studies of participants’perception of the intervention
or its impact on their lifestyle) [70].
Challenges of Quality Assessment
Health intervention researchers are not given instructions or
guidance about how to evaluate these mHealth apps or which
additional evidence is needed to determine their comprehensive
impacts on patients and providers. The recent addition of
connected technologies, such as wearables and sensors, has
introduced even more factors to the evaluation context.
Interventions now vary from recording exercise, to decision
support for patient self-management, to providing evidence of
a patients’ actions for health care providers, to review from a
variety of data sources. Because of these new information
sources, we cannot always anticipate all of the impacts of these
diverse networks of mHealth self-management technologies.
For example, 10 studies did not intend to obtain results related
to certain factors, such as usage logs and patient-reported
outcomes [41,42,44,50,53,63].
The assessment of a study’s success, validity, or quality presents
another challenge to traditional research practice. mHealth
resources consist of factors that make standard quality
assessments inconclusive for intervention studies. For example,
identifying patterns of patient self-management habits and
progress describes the impact of an mHealth intervention on a
patient’s behavior. However, the analysis of usage logs, as a
measure of intervention effectiveness, patient engagement, or
self-management practices, has been minimally investigated as
an appropriate method. As demonstrated by some of the
reviewed articles, usage logs, download counts, and online
ratings of apps were interpreted as indications of patient
engagement, self-management behavior, intervention reach
[41], effectiveness, and intervention utility [40] or feasibility.
Comparing Objectives and Results to Determine
Successful Use of Methods
As opposed to completing a formal quality assessment, we chose
to determine whether a study was able to produce the evidence
that it aimed to provide, using selected methods. Some studies
that performed usage log analysis were able to produce more
information than they anticipated. Possemato et al [42] stated
their intention to assess the fidelity of the PTSD Coach
intervention by comparing health care utilization and health
outcomes between those who used the app with and without
clinical support. They were able to provide evidence for the
effectiveness and fidelity of the intervention among health care
providers, symptoms, and clinical health parameters from
questionnaires. Moreover, they provided evidence for
participants’ patterns of intervention use from usage logs.
Thereby, they were able to discuss the relationship between
health care provider involvement and reinforced use of the app,
as patients may have felt more accountable for using the app to
self-manage their post-traumatic stress disorder.
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Among the 31 studies identified, one did not obtain all of the
intended information (missing one of the intended outcomes)
[35] and one was found to be inconclusive [53]. We found that
it was challenging to determine the specific objective of a study
when objectives were not stated as such or when they were
vague. This made it difficult to determine if a study was
successful in the use of its selected methods and study design
to reach its goals. For example, Velardo et al [62] stated that
they intended to evaluate the EDGE digital health system
intervention at scale; however, they did not state how they
intended to do so or provide a research question that they
intended to answer. Sieber et al [63] did not state the objective
of their study. Instead, they stated simply what was done (ie,
investigated the effects of usage profiles on hemoglobin A1c).
Without a stated objective, we are unable to judge the reliability
of intervention studies, whether it be through standard traditional
means or an alternative approach. Clear objectives must be
included in order to validate mHealth resources as trustworthy
and relevant measures for evaluating mHealth interventions.
Relevance
mHealth must work for health care providers as well as patients.
Patients are more engaged in their health, and they incorporate
mHealth into their self-management. Thus, patients are aware
of and can even influence how an mHealth intervention should
or could be used to influence the kind of impact that is relevant
for them. Understanding the potential risks and benefits of
patient-operated mHealth requires more continuous evidence
of not only technical and clinical outcomes but also personal
and psychological impacts. This review demonstrates, through
the use of such measures as mHealth interactions and
patient-gathered data via an app, that we as researchers have
the resources at our disposal and are beginning to use them.
A 2016 study by Pham et al [71] called for alternative or
additional methods and measures for mHealth clinical trials that
address the additional needs of mHealth. As most mHealth
technologies for chronic health self-management are intended
to be always available and continuously used by the patient,
research questions, approaches, and designs need to reflect the
real-world situations in which patients use these apps and
systems.
Several studies within the presented scoping review
demonstrated an attempt to meet this call by including more
flexibility in their intervention design. For example, the EDGE
digital health system [62], PTSD Coach app [42,43], and
HeartKeeper app [40] made the patient the “decision maker”
by allowing the patient to choose which data are relevant for
them to gather and share with their health care providers.
Further, two studies focused on reporting that patient
engagement improved as a result of using mHealth apps [36,52].
User engagement is a necessity for the success of any
intervention. It is paramount to consider patients’ intentions
when using these apps outside of the clinic; we should deem an
app’s ability to engage patients with their health as necessary
as clinical evidence. There are individuals who do not choose
to manage their chronic illnesses at all, for example, those
deemed “hard to reach,” who may benefit from merely
acknowledging their health challenge by using an app primarily
for education, without the expectation of performing
complicated and time-consuming self-management. Therefore,
when judging the success, usefulness, or potential benefit of an
evaluated mHealth intervention, there should be less of a
hierarchical gap between clinical health change or improvement
and patients’ experiences and change in self-efficacy.
Limitations
We believe our review covers most of the articles that were
published during the established period and dealt with mHealth
interventions for chronic conditions. This review reported on
patient-operated mHealth self-management and did not include
other potentially relevant interventions, such as SMS-based
interventions.
We chose to focus on self-management of chronic NCDs, as
defined by the WHO, in addition to severe mental health
conditions, according to the demand for solutions from two
fields (the medical system and public app development market)
[4,13,33,72]. As such, these health cases represented the most
potential for including state-of-the-art technology studies, with
chronically ill people consistently being the leading market.
However, exclusion of preventive treatments and other chronic
health challenges (eg, musculoskeletal diseases) may have
excluded a large proportion of cases that both involve the use
of self-management options and represent a relevant portion of
the chronic disease burden for individuals and health care
systems worldwide [73]. As such, this noninclusion may have
omitted conditions that could have provided relevant insights
into methods and measures used to assess motivational,
educational, and empowering mHealth technologies for
self-management.
Because we did not collect data on reported results for this
scoping review and did not perform a systematic methodological
quality assessment, we cannot comment on the usefulness or
effectiveness of the mHealth app and system interventions
presented in these studies.
Conclusion
Researchers are now using several mHealth resources to evaluate
mHealth interventions for patient self-management of select
NCDs. This is evident as studies relied mostly on more
continuous measures, including usage logs
[36,38,40-42,44,48-50,52,54,56-59,62-64] and patient-collected
data from medical devices [54,56,57,60,62,64], in addition to
pre-post measures, such as clinical health measures
[36,40,48,54-56,63,64] and standardized questionnaires
[35-39,41-45,48,49,55-57,60,64]. In doing so, they evaluated
the health status, engagement, and feasibility of mHealth apps
and systems. In this review, which focused on mHealth, we
found that only 20% of the included studies relied solely on
traditional study designs (eg, RCTs) and methods that measure
only pre- and postintervention health changes. The findings
illustrate that the tradition of focusing on “clinical effectiveness,
cost-effectiveness, and safety” [74] or health-related quality of
life and the use of health care resources [75] is not being
replaced, but is instead being expanded by taking advantage of
additional resources that mHealth provides to evaluate
interventions.
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There is still no clear standard for the evaluation of mHealth
interventions for patient self-management of chronic conditions.
However, because mHealth presents additional challenges,
needs, and resources to the field of health intervention research,
we have the opportunity to expand and maintain our relevance
to patients, providers, and health authorities. mHealth provides
new types of information that we can and should gather to
determine the impact of the interventions.
The presented results demonstrate that health studies have
started to take advantage of additional mHealth resources, such
as app usage logs and other patient-involved research methods,
to determine the comprehensive impacts of mHealth on patients
and other stakeholders. We are able to not only answer
questions, such as which tasks patients choose to perform during
interventions that may affect their clinical outcomes, but also
say more about the relevance of mHealth for various types of
users. This is essential in health intervention research, as the
call for evidence on mHealth continues to push for not only
traditional clinical health measures but also impacts on patients’
self-efficacy and engagement. We believe that to achieve a
compromise between the rigidity of traditional quality standards
and the push for more patient-relevant outcomes, the definition
of quality or meaningful impact, as well as available and
appropriate evidence should be reassessed.
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